Conceptus (CPTS) Wins Patent Infringement Case Against Hologic (HOLX); Will Receive $18.8M
Tweet
Share
E-mailGet Alerts CPTS Hot Sheet
Join SI Premium – FREE
Conceptus, Inc. (Nasdaq: CPTS), has won a favorable jury verdict in its patent infringement lawsuit against Hologic, Inc. (Nasdaq: HOLX) in the United States District Court, Northern District of California. The jury has awarded Conceptus $18.8 million in monetary damages.
The jury found that use of Hologic's Adiana Permanent Contraception system infringed two claims of Conceptus' U.S. Patent Number 6,634,361 related to the Essure procedure, and that Hologic indirectly infringed those claims. The jury also upheld the validity of the claims.
Conceptus will seek an injunction prohibiting Hologic from importing, using, selling or offering to sell its Adiana system in the United States. This issue will be addressed by the Court in future proceedings.
The jury found that use of Hologic's Adiana Permanent Contraception system infringed two claims of Conceptus' U.S. Patent Number 6,634,361 related to the Essure procedure, and that Hologic indirectly infringed those claims. The jury also upheld the validity of the claims.
Conceptus will seek an injunction prohibiting Hologic from importing, using, selling or offering to sell its Adiana system in the United States. This issue will be addressed by the Court in future proceedings.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Introduces New AI Capabilities to Help Organizations Boost Sales
- CAVA Group (CAVA) Enters the Midwest with its First Chicago Restaurant
- Immunome Inc. (IMNM) Appoints Sandra M. Swain to its Board
Create E-mail Alert Related Categories
Corporate News, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
